N-3 Fatty Acids for the Prevention of Atrial Fibrillation in Patients With Acute Heart Failure

Osaka General Medical Center

Status and phase: Unknown; Phase 4

Conditions: Acute Heart Failure; Acute Myocardial Infarction

Treatments: Drug: Epadel, Eicosapentaenoic acid

Study type: Interventional

Funder types: Other

Identifiers

NCT00692718

OFAHeft

Details and patient eligibility

About

Our study is to investigate the effect of N-3 Fatty Acids for the prevention of atrial fibrillation in patients with acute heart failure or acute myocardial infarction

Enrollment: 160 estimated patients

Sex: All

Ages: 20+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• sinus rhythm patients with acute heart failure or acute myocardial infarction

Exclusion criteria

• pregnancy,allergy to epadel

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)